SEC Form 13F
| Report period | 2025-12-31 |
|---|---|
| Publicly available | 2026-02-14 |
| Reported value | $22,054 |
| Positions | 3 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| NAUTILUS BIOTECHNOLOGY INC | NAUT | COM | $11,741 | 6,020,770 |
| UIPATH INC | PATH | CL A | $9,960 | 607,673 |
| GINKGO BIOWORKS HOLDINGS, INC. | DNA | CL A | $353 | 42,430 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.